Patients Diagnosed With Diabetes Are at Increased Risk for Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Fibrosis, and Pneumonia but Not Lung Cancer
暂无分享,去创建一个
[1] Aynur Gulcan,et al. Evaluation of Glucose Tolerance Status in Patients with Asthma Bronchiale , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.
[2] H. Sørensen,et al. Diabetes, Glycemic Control, and Risk of Hospitalization With Pneumonia , 2008, Diabetes Care.
[3] L. Sharples,et al. Predicting Survival in Potentially Curable Lung Cancer Patients , 2008, Lung.
[4] P. Raskin,et al. Lung function changes related to diabetes mellitus. , 2007, Diabetes technology & therapeutics.
[5] G. Divine,et al. Protective effect of diabetes against metastasis in patients with non-small cell lung cancer. , 2007, Archives of internal medicine.
[6] S. Weiss,et al. Lung function in type 2 diabetes: the Normative Aging Study. , 2005, Respiratory medicine.
[7] R. Hubbard,et al. Lung function and glucose metabolism: an analysis of data from the Third National Health and Nutrition Examination Survey. , 2005, American journal of epidemiology.
[8] C. Roberts,et al. Diabetes and the risk of lung cancer. , 2005, Diabetes care.
[9] M. Knuiman,et al. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. , 2004, Diabetes care.
[10] D. Lawlor,et al. Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women’s Heart and Health Study , 2004, Diabetologia.
[11] P. Schnohr,et al. Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults , 2002, European Respiratory Journal.
[12] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[13] A. Reunanen,et al. Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus. , 1998, American journal of public health.
[14] J. Selby,et al. Excess Costs of Medical Care for Patients With Diabetes in a Managed Care Population , 1997, Diabetes Care.
[15] E. Barrett-Connor,et al. NIDDM, Impaired Glucose Tolerance, and Pulmonary Function in Older Adults: The Rancho Bernardo Study , 1996, Diabetes Care.
[16] P. Pozzilli,et al. Infections and Diabetes: Mechanisms and Prospects for Prevention , 1994, Diabetic medicine : a journal of the British Diabetic Association.
[17] F. Vannucci,et al. Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus. , 1994, Diabetes research and clinical practice.
[18] P Ducimetière,et al. Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status. , 1993, BMJ.
[19] N. Krieger. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. , 1992, American journal of public health.
[20] J. Manson,et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. , 1991, Archives of internal medicine.
[21] P. Schnohr,et al. Diabetes mellitus and ventilatory capacity: a five year follow-up study. , 1990, The European respiratory journal.
[22] D. Bell,et al. Transfer factor for carbon monoxide in patients with diabetes with and without microangiopathy. , 1989, Thorax.
[23] J. Kastrup,et al. Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. , 1989, The European respiratory journal.
[24] R E Smith,et al. The California Automated Mortality Linkage System (CAMLIS). , 1984, American journal of public health.
[25] D. Mannino,et al. COPD prevalence in southeastern Kentucky: the burden of lung disease study. , 2009, Chest.